Discovering small-molecule therapeutics against SARS-CoV-2 (original) (raw)

Profile image of Vaibhav TiwariVaibhav Tiwari

2020, Drug Discovery Today

visibility

description

11 pages

link

1 file

Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection

Rajiv Tonk

Reviews in Cardiovascular Medicine, 2020

View PDFchevron_right

In Silico Study Of Natural Compound Candidates As Promising Drugs For SARS-Cov-2

abeer sharfalddin

International Journal of Scientific & Technology Research, 2021

View PDFchevron_right

A new way to fight sars-cov-19

Valentyn Nastasenko

Materials Science and Nanotechnology, 2021

View PDFchevron_right

Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19

Gaurav Joshi

Cellular Signalling, 2020

View PDFchevron_right

Targeting natural products against SARS-CoV-2

Tanuj Upadhyay

Environmental Science and Pollution Research

View PDFchevron_right

In silico identification of approved drugs for potential prophylactic uses against SARS-CoV-2 infection

Ikemefuna Uzochukwu

Magna Scientia Advanced Biology and Pharmacy, 2024

View PDFchevron_right

OVERVIEW OF ANTIVIRAL DRUGS AGAINST SARS-CoV-2 FOR THE TREATMENT OF COVID-19

Marko Anderluh

Acta Medica Medianae, 2021

View PDFchevron_right

Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors

Niloofar Mohammadi

Informatics in Medicine Unlocked, 2020

View PDFchevron_right

COVID-19 and SARS-CoV-2: Despite the vaccination, new targets/drugs for treatment and the virus cycle mechanisms still have to be continually investigated

Marcia Rodrigues Amorim

Open Journal of Proteomics and Genomics, 2021

View PDFchevron_right

Recent advances in computational drug discovery for therapy against coronavirus SARS-CoV-2

Oleg Kalugin

ScienceRise. Pharmaceutical science, 2023

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus

Simona Iacob

Frontiers in Pharmacology, 2020

View PDFchevron_right

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Elena Moreno

Nature, 2020

View PDFchevron_right

Race to arsenal COVID-19 therapeutics: Current alarming status and future directions

Ankit Kumar Dubey

Chemico-Biological Interactions, 2020

View PDFchevron_right

Current trends and possible therapeutic options against COVID-19

Uzair Ahmed

Journal of Microbiology and Infectious Diseases, 2020

View PDFchevron_right

Interaction between SARS-CoV-2 and human organism

Valentin Cebotarescu

2020

View PDFchevron_right

SARS-CoV-2 neutralizing antibody development strategies

muge serhatli

TURKISH JOURNAL OF BIOLOGY

View PDFchevron_right

Emerging Therapeutic Options for COVID-19

sheetal khubchandani

Journal of Evolution of Medical and Dental Sciences, 2020

View PDFchevron_right

Using in vivo animal models for studying SARS-CoV-2

Norman A Ratcliffe

Expert Opinion on Drug Discovery, 2021

View PDFchevron_right

Molecular modelling studies to suggest novel scaffolds against SARS-CoV-2 target enzymes

Ş.Güniz Küçükgüzel

Journal of research in pharmacy, 2021

View PDFchevron_right

Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing

Prabhat Tomar

Viruses, 2021

View PDFchevron_right

Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets

ahmed abdullh mohamed

Chemical Papers, 2021

View PDFchevron_right

Some Recent Facts about SARS-CoV-2

Dr. Parul Thapar

Acta Scientific Microbiology, 2020

View PDFchevron_right

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids

xiaohua duan

Nature, 2020

View PDFchevron_right

Drugs for COVID-19 Treatment: A New Challenge

Arunima Saha

Applied Biochemistry and Biotechnology

View PDFchevron_right

Previous and potential mutations of Sars-cov-2 receptors and their interaction with known inhibitors

Ikemefuna Uzochukwu

GSC biological and pharmaceutical sciences, 2023

View PDFchevron_right

Antiviral drug discovery: preparing for the next pandemic

Rosemary Dorrington

Chemical Society Reviews, 2021

View PDFchevron_right

Production and Formation of SARS-CoV-2 Variants

shaista nawaz

IntechOpen eBooks, 2024

View PDFchevron_right

Brief Facts about COVID-19 (SARS-CoV-2)

Sorush Niknamian

Journal of Surgery Research and Practice, 2021

View PDFchevron_right

In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals

yusuf şimşek

Journal of Molecular Graphics and Modelling, 2021

View PDFchevron_right

SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines

Laura Bonifaz

Boletín Médico del Hospital Infantil de México

View PDFchevron_right

Progress in the Development of Potential Therapeutics and Vaccines against COVID-19 Pandemic

vikramdeep monga

Acta Scientific Pharmaceutical Sciences, 2021

View PDFchevron_right

Recent biotechnological approaches for treatment of novel COVID-19: from bench to clinical trial

Mojtaba Mousavi

Drug Metabolism Reviews, 2020

View PDFchevron_right

Natural products and phytochemicals as potential anti‐SARS‐CoV ‐2 drugs

Bina Das

Phytotherapy Research, 2021

View PDFchevron_right

Evaluation of Treatment of Patients with SARS-CoV-2 in line with Literature

Çağatay ONAR

Maltepe Tıp Dergisi, 2020

View PDFchevron_right

Recent Advancements on COVID-19: A Comprehensive Review

Darya Abdulateef

International Journal of General Medicine, 2021

View PDFchevron_right

MedicinePharmacology and pharmaceutical ...